Skip to content

Spinal anaesthesia with chloroprocain versus total intravenous anaesthesia for outpatient knee arthroscopy

Spinal anaesthesia with chloroprocain versus total intravenous anaesthesia for outpatient knee arthroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005989
Enrollment
80
Registered
2014-04-15
Start date
2014-04-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases or conditions that indicate to an outpatient knee arthroscopy M23

Interventions

Group 1: Spinal anaesthesia using 40mg chloroprocaine 1% for outpatient knee-arthroscopy. The hight of sensory and motor block as well as the decay of the block is documented. Measured are time-spans

Sponsors

Klinik für Anästhesiologie und Operative Intensivmedizin der Universitätsmedizin Mannheim
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients (male/female) with outpatient knee arthroscopy 2. Age 18-80 years 3. American Society of Anesthesiologists (ASA) physical status I-III

Exclusion criteria

Exclusion criteria: 1. Contraindications for spinal anaesthesia as well as general anaesthesia 2. Allergy to one of the used drugs for spinal- or general-anaesthesia or for postoperative analgesia

Design outcomes

Primary

MeasureTime frame
Duration of stay in the day-surgery centre measured from anaesthesia induction until discharge in minutes.

Secondary

MeasureTime frame
- first occurrence of pain after anaesthesia induction, measured in minutes - Patient’s overall satisfaction and quality of recovery, measured by QoR9-Questionaire and a standardized interview - adverse side effects, measured by a standardized telephone-interview 7 days after the operation

Countries

Germany

Contacts

Public ContactVolker Gebhardt

Klinik für Anästhesiologie und Operative Intensivmedizin der Universitätsmedizin Mannheim

volker.gebhardt@umm.de0621-2415

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 24, 2026